Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Tirzepatide is a different molecule with a separate patent portfolio
Patients received a 3-week treatment with dulaglutide (1.5 mg) or placebo (0.9% sodium chloride) subcutaneously once weekly and attended an 8-hour evaluation visit during the last treatment week
These factors include: Location: Prices in big cities where the cost of living will be higher and vice-versa
Most patients return to treatment three to six months after weaning
The FormBlends alternative for Illinois Medicaid patients For Illinois Medicaid patients who are denied coverage for Wegovy or Zepbound, or who don't want to navigate the prior authorization process, compounded semaglutide and tirzepatide are available through FormBlends at out-of-pocket cost
